Bronte Capital Management Pty Ltd. Albemarle Corp Transaction History

Bronte Capital Management Pty Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	BUY	$172.91 - $232.22 $27,146 - $36,458	157 Added 0.82%	19,306 $4.31 Million
Q1 2023 May 12, 2023	SELL	$208.49 - $290.15 $4.55 Million - $6.34 Million	-21,840 Reduced 53.28%	19,149 $4.23 Million
Q4 2022 Feb 13, 2023	SELL	$214.02 - $325.38 $193,688 - $294,468	-905 Reduced 2.16%	40,989 $8.89 Million
Q3 2022 Nov 02, 2022	SELL	$195.82 - $307.05 $2.53 Million - $3.97 Million	-12,916 Reduced 23.57%	41,894 $11.1 Million
Q2 2022 Aug 08, 2022	BUY	$187.76 - $270.92 $10.3 Million - $14.8 Million	54,810 New	54,810 $11.5 Million

927

104M

8.36M

14.3M

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $10.4B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Bronte Capital Management Pty Ltd., based on Form 13F filings with the SEC.

Stay updated on Bronte Capital Management Pty Ltd. with notifications on news.